Related references
Note: Only part of the references are listed.Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)
Louise J. Murray et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma
Ting-Shi Su et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score
J. Edeline et al.
EUROPEAN JOURNAL OF CANCER (2017)
Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy
Cheng-Hsiang Lo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma
Ting-Shi Su et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era
Po-Hong Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
David J. Pinato et al.
JOURNAL OF HEPATOLOGY (2017)
Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma
Jan Hansmann et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation
Wei-Yu Kao et al.
RADIOLOGY (2017)
Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function
Atsushi Hiraoka et al.
LIVER CANCER (2017)
Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer
Diego A. S. Toesca et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients
Ting-Shi Su et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Analysis of risk and predictors of brain radiation necrosis after radiosurgery
Hongqing Zhuang et al.
ONCOTARGET (2016)
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
Ting-Shi Su et al.
BMC CANCER (2016)
Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma
Y. -Y. Wang et al.
BRITISH JOURNAL OF SURGERY (2016)
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma
Julien Edeline et al.
LIVER INTERNATIONAL (2016)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatobiliary Cancers, Version 2.2014
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Share Paper
